Abstract:Both normal aging and dementia are associated with dysregulation of the biological clock, which contributes to disrupted circadian organization of physiology and behavior. Diminished circadian organization in conjunction with the loss of cholinergic input to the cortex likely contributes to impaired cognition and behavior. One especially notable and relatively common circadian disturbance among the aged is “sundowning syndrome,” which is characterized by exacerbated anxiety, agitation, locomotor activity, and delirium during the hours before bedtime. Sundowning has been reported in both dementia patients and cognitively intact elderly individuals living in institutions; however, little is known about temporal patterns in anxiety and agitation, and the neurobiological basis of these rhythms remains unspecified. In the present study, we explored the diurnal pattern of anxiety-like behavior in aged and amyloid precursor protein (APP) transgenic mice. We then attempted to treat the observed behavioral disturbances in the aged mice using chronic nightly melatonin treatment. Finally, we tested the hypothesis that time-of-day differences in acetylcholinesterase and choline acetyltransferase expression and general neuronal activation (i.e., c-Fos expression) coincide with the behavioral symptoms. Our results show a temporal pattern of anxiety-like behavior that emerges in elderly mice. This behavioral pattern coincides with elevated locomotor activity relative to adult mice near the end of the dark phase, and with time-dependent changes in basal forebrain acetylcholinesterase expression. Transgenic APP mice show a similar behavioral phenomenon that is not observed among age-matched wild-type mice. These results may have useful applications to the study and treatment of age- and dementia-related circadian behavioral disturbances, namely, sundowning syndrome.

Regulation of Sleep Behavior by Overexpression of Amyloid Precursor Protein in Drosophila Neurons

Establishment of a Drosophila AD Model

Upregulation of IP3 receptor mediates APP-induced defects in synaptic downscaling and sleep homeostasis

Depletion of ESCRT Ameliorates APP-induced AD-like Symptoms in Drosophila

Resveratrol and Sir2 Reverse Sleep and Memory Defects Induced by Amyloid Precursor Protein

Aberrant Axonal Arborization of PDF Neurons Induced by Aβ42-Mediated JNK Activation Underlies Sleep Disturbance in an Alzheimer’s Model

Regulation of proteostasis by sleep through autophagy in Drosophila models of Alzheimer's disease

Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila

Amnesiac Regulates Sleep Onset and Maintenance in Drosophila Melanogaster.

Behavioural Effects and RNA-seq Analysis of Aβ42-Mediated Toxicity in a Drosophila Alzheimer's Disease Model

Chronic sleep deprivation exacerbates cognitive and synaptic plasticity impairments in APP/PS1 transgenic mice

Dissecting the Pathological Effects of Human Aβ40 and Aβ42 in Drosophila : A Potential Model for Alzheimer's Disease

Orexin A peptidergic system: comparative sleep behavior, morphology and population in brains between wild type and Alzheimer’s disease mice

Orexin A peptidergic system: Comparative physiology, morphology and population between brains of nomal and Alzheimer’s disease mice

Loss of Polo Ameliorates APP-induced Alzheimer's Disease-Like Symptoms in Drosophila.

Disrupted Prefrontal Neuronal Oscillations and Morphology Induced by Sleep Deprivation in Young APP/PS1 Transgenic AD Mice

<i>CHIP</i> modulates APP-induced autophagy-dependent pathological symptoms in <i>Drosophila</i>

Altered temporal patterns of anxiety in aged and amyloid precursor protein (APP) transgenic mice

0429 Chronic Sleep Disturbance Causes Cognitive Impairment and Alzheimer’S Disease-Like Neuropathology

Age-dependent alterations in the presynaptic active zone in a Drosophila model of Alzheimer's disease.

Dissecting The Pathological Effects Of Human A Beta 40 And A Beta 42 In Drosophila: A Potential Model For Alzheimer'S Disease